[1]
|
Pui, C.H., Mullighan, C.G., Evans, W.E., et al. (2012) Pediatric Acute Lymphoblastic Leukemia: Where Are We Going and How Do We Get There? Blood, 120, 1165-1174. https://doi.org/10.1182/blood-2012-05-378943
|
[2]
|
Parikh, S.A. and Litzow, M.R. (2014) Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Therapies under Development. Future Oncology, 10, 2201-2212. https://doi.org/10.2217/fon.14.81
|
[3]
|
阮永胜, 吴学东, 冯晓勤, 等. ALL-BFM95方案治疗儿童急性淋巴细胞白血病高危患儿的预后分析[J]. 中国当代儿科杂志, 2015(4): 327-331.
|
[4]
|
阮永胜, 吴学东. 儿童急性淋巴细胞白血病复发的研究进展[J]. 中华临床医师杂志(电子版), 2014(18): 3359-3363.
|
[5]
|
Fragoso, R. and Barata, J.T. (2014) PTEN and Leukemia Stem Cells. Advances in Biological Regulation, 56, 22-29.
https://doi.org/10.1016/j.jbior.2014.05.005
|
[6]
|
Schofield, R. (1978) The Relationship between the Spleen Colo-ny-Forming Cell and the Haemopoietic Stem Cell. Blood Cells, 4, 7-25.
|
[7]
|
Tabe, T. and Konopleva, M. (2014) Advances in Understanding the Leukaemia Microenvironment. British Journal of Haematology, 164, 767-778. https://doi.org/10.1111/bjh.12725
|
[8]
|
Colmone, A., Amorim, M., Pontier, A.L., et al. (2008) Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells. Science, 322, 1861-1865. https://doi.org/10.1126/science.1164390
|
[9]
|
Hazlehurst, L.A., Argilagos, R.F. and Dalton, W.S. (2007) Beta1 Integrin Mediated Adhesion Increases Bim Protein Degradation and Contributes to Drug Resistance in Leukaemia Cells. British Journal of Haematology, 136, 269-275.
https://doi.org/10.1111/j.1365-2141.2006.06435.x
|
[10]
|
陈幸华, 高蕾, 张曦, 等. 新型白血病骨髓基质细胞黏附介导耐药模型构建的探索性研究[J]. 中华医学杂志, 2007, 87(20): 1380-1383.
|
[11]
|
Mudry, R.E., Fortney, J.E., York, T., et al. (2000) Stromal Cells Regulate Survival of B-Lineage Leukemic Cells during Chemotherapy. Blood, 96, 1926-1932.
|
[12]
|
Hynes, R.O. (2002) Integrins: Bidirectional, Allosteric Signaling Machines. Cell, 110, 673-687.
https://doi.org/10.1016/S0092-8674(02)00971-6
|
[13]
|
Streuli, C.H. and Akhtar, N. (2009) Signal Co-Operation between Integrins and Other Receptor Systems. Biochemical Journal, 418, 491-506. https://doi.org/10.1042/BJ20081948
|
[14]
|
Cabodi, S., Moro, L., Bergatto, E., et al. (2004) Integrin Regulation of Epi-dermal Growth Factor (EGF) Receptor and of EGF-Dependent Responses. Biochemical Society Transactions, 32, 438-442. https://doi.org/10.1042/bst0320438
|
[15]
|
Guo, W. and Giancotti, F.G. (2004) Integrin Signalling during Tumour Pro-gression. Nature Reviews Molecular Cell Biology, 5, 816-826. https://doi.org/10.1038/nrm1490
|
[16]
|
Tabe, Y., Jin, L., Tsutsumi-Ishii, Y., et al. (2007) Activation of Integrin-Linked Kinase Is a Critical Prosurvival Pathway Induced in Leukemic Cells by Bone Marrow-Derived Stromal Cells. Cancer Research, 67, 684-694.
https://doi.org/10.1158/0008-5472.CAN-06-3166
|
[17]
|
Lim, C.J., Han, J., Yousefi, N., et al. (2007) Alpha4 Integrins Are Type I cAMP-Dependent Protein Kinase-Anchoring Proteins. Nature Cell Biology, 9, 415-421. https://doi.org/10.1038/ncb1561
|
[18]
|
Rivera Rosado, L.A., Horn, T.A., McGrath, S.C., et al. (2011) Association be-tween alpha4 Integrin Cytoplasmic Tail and Non-Muscle Myosin IIA Regulates Cell Migration. Journal of Cell Science, 124, 483-492.
https://doi.org/10.1242/jcs.074211
|
[19]
|
Fortney, J.E., Hall, B.M., Bartrug, L., et al. (2002) Chemotherapy Induces bcl-2 Cleavage in Lymphoid Leukemic Cell Lines. Leuk Lymphoma, 43, 2171-2178. https://doi.org/10.1080/1042819021000033024
|
[20]
|
Wang, L., Fortney, J.E. and Gibson, L.F. (2004) Stromal Cell Protection of B-Lineage Acute Lymphoblastic Leukemic Cells during Chemotherapy Requires Active Akt. Leukemia Research, 28, 733-742.
https://doi.org/10.1016/j.leukres.2003.10.033
|
[21]
|
Nwabo Kamdje, A.H. and Krampera, M. (2011) Notch Signaling in Acute Lymphoblastic Leukemia: Any Role for Stromal Microenvironment? Blood, 118, 6506-6514. https://doi.org/10.1182/blood-2011-08-376061
|
[22]
|
Bertrand, F.E., Spengemen, J.D., Shelton, J.G., et al. (2005) Inhi-bition of PI3K, mTOR and MEK Signaling Pathways Promotes Rapid Apoptosis in B-Lineage ALL in the Presence of Stromal Cell Support. Leukemia, 19, 98-102.
https://doi.org/10.1038/sj.leu.2403560
|
[23]
|
Jacamo, R., Chen, Y., Wang, Z., et al. (2014) Reciprocal Leukemia-Stroma VCAM-1/VLA-4-Dependent Activation of NF-kB Mediates Chemoresistance. Blood, 123, 2691-2702. https://doi.org/10.1182/blood-2013-06-511527
|
[24]
|
Yu, Y., Schurpf, T. and Springer, T.A. (2013) How Natalizumab Binds and Antagonizes alpha4 Integrins. The Journal of Biological Chemistry, 288, 32314-32325. https://doi.org/10.1074/jbc.M113.501668
|
[25]
|
Hsieh, Y.T., Gang, E.J., Geng, H., et al. (2013) Integrin alpha4 Blockade Sensitizes Drug Resistant pre-B Acute Lymphoblastic Leukemia to Chemotherapy. Blood, 121, 1814-1818. https://doi.org/10.1182/blood-2012-01-406272
|
[26]
|
Schwab, N., Schneider-Hohendorf, T., Melzer, N., et al. (2017) Natalizumab-Associated PML Challenges with Incidence, Resulting Risk, and Risk Stratification. Neurology, 88, 1197-1205.
https://doi.org/10.1212/WNL.0000000000003739
|
[27]
|
Shishido, S., Bönig, H. and Kim, Y.M. (2014) Role of Integrin Alpha4 in Drug Resistance of Leukemia. Frontiers in Oncology, 4, 99. https://doi.org/10.3389/fonc.2014.00099
|
[28]
|
Hsieh, Y.T., Gang, E.J. and Shishido, S.N. (2014) Effects of the Small-Molecule Inhibitor of Integrin A4, TBC3486, on Pre-B-ALL Cells. Leukemia, 28, 2101-2104. https://doi.org/10.1038/leu.2014.182
|
[29]
|
Ruan, Y., Gang, E.J., Kim, H.N., et al. (2016) AVA4746, an Orally Available, Clinical Grade Antagonist of Integrin Alpha 4, Sensitizes Pre-B Cell Acute Lymphoblastic Leukemia to Chemotherapy. Blood, 128, 2765.
|